You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Aspen Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ASPEN, and what generic and branded alternatives to ASPEN drugs are available?

ASPEN has nine approved drugs.

Summary for Aspen

US Patents:	0
Tradenames:	10
Ingredients:	8
NDAs:	9

Drugs and US Patents for Aspen

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aspen	ENJUVIA	estrogens, conjugated synthetic b	TABLET;ORAL	021443-004	May 10, 2004		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Aspen	ENJUVIA	estrogens, conjugated synthetic b	TABLET;ORAL	021443-005	Apr 27, 2007		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Aspen	ENJUVIA	estrogens, conjugated synthetic b	TABLET;ORAL	021443-001	Dec 20, 2004		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Aspen	ENJUVIA	estrogens, conjugated synthetic b	TABLET;ORAL	021443-003	May 10, 2004		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Aspen	CENESTIN	estrogens, conjugated synthetic a	TABLET;ORAL	020992-005	Feb 5, 2004		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
Aspen Global Inc	LIQUAEMIN SODIUM	heparin sodium	INJECTABLE;INJECTION	000552-004	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Aspen Global Inc	LIQUAEMIN SODIUM	heparin sodium	INJECTABLE;INJECTION	000552-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Aspen

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Aspen Global Inc	ORGARAN	danaparoid sodium	INJECTABLE;INJECTION	020430-001	Dec 24, 1996	5,164,377	⤷ Sign Up
Aspen	ENJUVIA	estrogens, conjugated synthetic b	TABLET;ORAL	021443-005	Apr 27, 2007	6,855,703	⤷ Sign Up
Aspen	ENJUVIA	estrogens, conjugated synthetic b	TABLET;ORAL	021443-005	Apr 27, 2007	6,660,726	⤷ Sign Up
Aspen	CENESTIN	estrogens, conjugated synthetic a	TABLET;ORAL	020992-001	Jun 21, 2002	5,908,638	⤷ Sign Up
Aspen	CENESTIN	estrogens, conjugated synthetic a	TABLET;ORAL	020992-003	Mar 24, 1999	5,908,638	⤷ Sign Up
Aspen	CENESTIN	estrogens, conjugated synthetic a	TABLET;ORAL	020992-004	Mar 13, 2000	5,908,638	⤷ Sign Up
Aspen Global Inc	CYCLESSA	desogestrel; ethinyl estradiol	TABLET;ORAL-28	021090-001	Dec 20, 2000	4,628,051	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for ASPEN drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Tablets	0.625 mg	➤ Subscribe	2009-03-02
➤ Subscribe	Tablets	1.25 mg	➤ Subscribe	2008-11-03
➤ Subscribe	Tablets	0.3 mg, 0.45 mg and 0.9 mg	➤ Subscribe	2009-03-19

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.